🇺🇸 FDA
Pipeline program

Methylphenidate HCl ER tablets 1

2015P001113

Unknown small_molecule completed

Quick answer

Methylphenidate HCl ER tablets 1 for Attention Deficit Hyperactivity Disorder is a Unknown program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Attention Deficit Hyperactivity Disorder
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials